Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes

Microorganisms - Tập 7 Số 9 - Trang 320
Elena Barengolts1,2, Stefan J. Green3, George E. Chlipala4, Brian T. Layden1,2, Yuval Eisenberg1, Medha Priyadarshini1, Lara R. Dugas5
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
2Section of Endocrinology, Department of Medicine, Jesse Brown VA Medical Center, Chicago, IL 60612, USA
3Sequencing Core, Research Resources Center, University of Illinois, Chicago, IL 60612, USA
4Research Informatics Core, Research Resources Center, University of Illinois, Chicago, IL 60612, USA
5Department of Public Health Sciences, Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, IL 60153, USA

Tóm tắt

Gut microbiota and their biomarkers may be associated with obesity. This study evaluated associations of body mass index (BMI) with circulating microbiota biomarkers in African American men (AAM) (n = 75). The main outcomes included fecal microbial community structure (16S rRNA), gut permeability biomarkers (ELISA), and short-chain fatty acids (SCFAs, metabolome analysis). These outcomes were compared between obese and non-obese men, after adjusting for age. The results showed that lipopolysaccharide-binding protein (LBP), the ratio of LBP to CD14 (LBP/CD14), and SCFAs (propionic, butyric, isovaleric) were higher in obese (n = 41, age 58 years, BMI 36 kg/m2) versus non-obese (n = 34, age 55 years, BMI 26 kg/m2) men. BMI correlated positively with LBP, LBP/CD14 (p < 0.05 for both) and SCFAs (propionic, butyric, isovaleric, p < 0.01 for all). In the regression analysis, LBP, LBP/CD14, propionic and butyric acids were independent determinants of BMI. The study showed for the first time that selected microbiota biomarkers (LBP, LBP/CD14, propionic and butyric acids) together with several other relevant risks explained 39%–47% of BMI variability, emphasizing that factors other than microbiota-related biomarkers could be important. Further research is needed to provide clinical and mechanistic insight into microbiota biomarkers and their utility for diagnostic and therapeutic purposes.

Từ khóa


Tài liệu tham khảo

(2019, August 21). WHO Obesity. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

(2019, August 21). WHO Diabetes. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes.

American Diabetes Association (2019). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care, 42, S90–S102.

American Diabetes Association (2019). 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care, 42, S81–S89.

American Diabetes Association (2019). 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2019. Diabetes Care, 42, S7–S12.

Jensen, 2014, 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society, Circulation, 129, S102, 10.1161/01.cir.0000437739.71477.ee

Backhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl. Acad. Sci. USA, 101, 15718, 10.1073/pnas.0407076101

Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414

Cummings, 1987, Short chain fatty acids in human large intestine, portal, hepatic and venous blood, Gut, 28, 1221, 10.1136/gut.28.10.1221

Wong, 2006, Colonic health: Fermentation and short chain fatty acids, J. Clin. Gastroenterol., 40, 235, 10.1097/00004836-200603000-00015

Groen, 2013, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J. Lipid Res., 54, 2325, 10.1194/jlr.R036012

Yen, 1991, Potential contribution of absorbed volatile fatty acids to whole-animal energy requirement in conscious swine, J. Anim. Sci., 69, 2001, 10.2527/1991.6952001x

Schwiertz, 2010, Microbiota and SCFA in lean and overweight healthy subjects, Obesity (Silver Spring), 18, 190, 10.1038/oby.2009.167

Teixeira, 2013, Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors, Br. J. Nutr., 109, 914, 10.1017/S0007114512002723

Fernandes, 2014, Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans, Int. J. Obes. (Lond.), 38, 1525, 10.1038/ijo.2014.46

Irving, B.A., Wood, G.C., Bennotti, P.N., Babu, E., Deshpande, A., Lent, M.R., Petrick, A., Gabrielsen, J., Strodel, W., and Gerhard, G.S. (2016). Nutrient Transporter Expression in the Jejunum in Relation to Body Mass Index in Patients Undergoing Bariatric Surgery. Nutrients, 8.

Psichas, 2015, The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents, Int. J. Obes. (Lond.), 39, 424, 10.1038/ijo.2014.153

Roshanravan, 2017, Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial, Horm. Metab. Res., 49, 886, 10.1055/s-0043-119089

Chambers, 2015, Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults, Gut, 64, 1744, 10.1136/gutjnl-2014-307913

Byrne, 2016, Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods, Am. J. Clin. Nutr., 104, 5, 10.3945/ajcn.115.126706

Wright, 1990, CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 249, 1431, 10.1126/science.1698311

Fasano, 2011, Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer, Physiol. Rev., 91, 151, 10.1152/physrev.00003.2008

Ortega, 2012, Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance, Int. J. Obes. (Lond.), 36, 1442, 10.1038/ijo.2011.256

Moreno-Navarrete, J.M., Sabater, M., Ortega, F., Ricart, W., and Fernandez-Real, J.M. (2012). Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE, 7.

Gonzalez-Quintela, A., Alonso, M., Campos, J., Vizcaino, L., Loidi, L., and Gude, F. (2013). Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: The role of obesity. PLoS ONE, 8.

Laugerette, 2014, Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14, Mol. Nutr. Food Res., 58, 1513, 10.1002/mnfr.201400044

Ciubotaru, 2015, Significant differences in fecal microbiota are associated with various stages of glucose tolerance in African American male veterans, Transl. Res., 166, 401, 10.1016/j.trsl.2015.06.015

Barengolts, 2016, Gut Microbiota, Prebiotics, Probiotics, and Synbiotics in Management of Obesity and Prediabetes: Review of Randomized Controlled Trials, Endocr. Pract., 22, 1224, 10.4158/EP151157.RA

Pei, 2018, Premeal Low-Fat Yogurt Consumption Reduces Postprandial Inflammation and Markers of Endotoxin Exposure in Healthy Premenopausal Women in a Randomized Controlled Trial, J. Nutr., 148, 910, 10.1093/jn/nxy046

Forslund, 2015, Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, 528, 262, 10.1038/nature15766

Yang, 2015, Gut dysbiosis is linked to hypertension, Hypertension, 65, 1331, 10.1161/HYPERTENSIONAHA.115.05315

Kelly, 2016, Gut Microbiome Associates with Lifetime Cardiovascular Disease Risk Profile among Bogalusa Heart Study Participants, Circ. Res., 119, 956, 10.1161/CIRCRESAHA.116.309219

Fond, 2015, The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review, Pathol. Biol. (Paris), 63, 35, 10.1016/j.patbio.2014.10.003

Barengolts, E., Green, S.J., Eisenberg, Y., Akbar, A., Reddivari, B., Layden, B.T., Dugas, L., and Chlipala, G. (2018). Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease. PLoS ONE, 13.

Barengolts, 2015, Effect of High-Dose Vitamin D Repletion on Glycemic Control in African-American Males with Prediabetes and Hypovitaminosis D, Endocr. Pract., 21, 604, 10.4158/EP14548.OR

(2019, January 20). Protocol from Shimadzu. Available online: https://www.shimadzu.com/an/lcms/mp_fattyacid-sc.html.

Begliuomini, 2008, Plasma brain-derived neurotrophic factor daily variations in men: Correlation with cortisol circadian rhythm, J. Endocrinol., 197, 429, 10.1677/JOE-07-0376

Naqib, 2018, Making and Sequencing Heavily Multiplexed, High-Throughput 16S Ribosomal RNA Gene Amplicon Libraries Using a Flexible, Two-Stage PCR Protocol, Methods Mol. Biol., 1783, 149, 10.1007/978-1-4939-7834-2_7

Zhang, 2014, PEAR: A fast and accurate Illumina Paired-End reAd mergeR, Bioinformatics, 30, 614, 10.1093/bioinformatics/btt593

Oksanen, J., Blanchet, F.G., Friendly, M., Kindt, R., Legendre, P., McGlinn, D., Minchin, P.R., O’Hara, R.B., Simpson, G.L., and Solymos, P. (2019, August 21). vegan: Community Ecology Package. Available online: https://cran.r-project.org/web/packages/vegan/index.html.

Sun, 2010, A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese, Diabetes Care, 33, 1925, 10.2337/dc10-0340

Yang, 2014, Bariatric surgery decreased the serum level of an endotoxin-associated marker: Lipopolysaccharide-binding protein, Surg. Obes. Relat. Dis., 10, 1182, 10.1016/j.soard.2014.02.022

Tilves, 2016, Association of Lipopolysaccharide-Binding Protein with Aging-Related Adiposity Change and Prediabetes among African Ancestry Men, Diabetes Care, 39, 385, 10.2337/dc15-1777

Leber, 2012, The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: An open label, randomized pilot study, Eur. J. Clin. Nutr., 66, 1110, 10.1038/ejcn.2012.103

Serrano, 2013, Serum lipopolysaccharide-binding protein as a marker of atherosclerosis, Atherosclerosis, 230, 223, 10.1016/j.atherosclerosis.2013.07.004

Ruiz, 2007, Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: Evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis, Obes. Surg., 17, 1374, 10.1007/s11695-007-9243-7

Tremellen, 2017, Metabolic endotoxaemia related inflammation is associated with hypogonadism in overweight men, Basic. Clin. Androl., 27, 5, 10.1186/s12610-017-0049-8

Liu, 2014, Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: A prospective study among middle-aged and older Chinese, Diabetologia, 57, 1834, 10.1007/s00125-014-3288-7

Escote, 2013, A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction, Diabetologia, 56, 2524, 10.1007/s00125-013-3015-9

Escote, 2015, Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation, Diabetologia, 58, 2424, 10.1007/s00125-015-3692-7

Cairo, 2016, Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans, Diabetologia, 59, 2208, 10.1007/s00125-016-4028-y

Borgo, F., Riva, A., Benetti, A., Casiraghi, M.C., Bertelli, S., Garbossa, S., Anselmetti, S., Scarone, S., Pontiroli, A.E., and Morace, G. (2017). Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests. PLoS ONE, 12.

Li, 2015, Increased Butyrate Production During Long-Term Fermentation of In Vitro-Digested High Amylose Cornstarch Residues with Human Feces, J. Food Sci., 80, M1997, 10.1111/1750-3841.12982

Xiao, 2014, A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome, FEMS Microbiol. Ecol., 87, 357, 10.1111/1574-6941.12228

Kong, L.C., Holmes, B.A., Cotillard, A., Habi-Rachedi, F., Brazeilles, R., Gougis, S., Gausseres, N., Cani, P.D., Fellahi, S., and Bastard, J.P. (2014). Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS ONE, 9.

Adamberg, 2018, Composition and metabolism of fecal microbiota from normal and overweight children are differentially affected by melibiose, raffinose and raffinose-derived fructans, Anaerobe, 52, 100, 10.1016/j.anaerobe.2018.06.009

Lin, A., Bik, E.M., Costello, E.K., Dethlefsen, L., Haque, R., Relman, D.A., and Singh, U. (2013). Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS ONE, 8.

Shankar, V., Gouda, M., Moncivaiz, J., Gordon, A., Reo, N.V., Hussein, L., and Paliy, O. (2017). Differences in Gut Metabolites and Microbial Composition and Functions between Egyptian and U.S. Children Are Consistent with Their Diets. mSystems, 2.

Jain, 2018, Similarities and differences in gut microbiome composition correlate with dietary patterns of Indian and Chinese adults, AMB Express., 8, 104, 10.1186/s13568-018-0632-1

Paggi, 2005, Growth and pectate-lyase activity of the ruminal bacterium Lachnospira multiparus in the presence of short-chain organic acids, Lett. Appl. Microbiol., 41, 434, 10.1111/j.1472-765X.2005.01717.x

Moran, 2014, Gut microbiota and obesity: Role in aetiology and potential therapeutic target, Best Pract. Res. Clin. Gastroenterol., 28, 585, 10.1016/j.bpg.2014.07.005

Hua, C., Geng, Y., Chen, Q., Niu, L., Cai, L., Tao, S., Ni, Y., and Zhao, R. (2018). Chronic dexamethasone exposure retards growth without altering the digestive tract microbiota composition in goats. BMC Microbiol., 18.

Deng, 2017, Ground transport stress affects bacteria in the rumen of beef cattle: A real-time PCR analysis, Anim. Sci. J., 88, 790, 10.1111/asj.12615

Lin, 2017, Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder, J. Affect. Disord., 207, 300, 10.1016/j.jad.2016.09.051

Xu, 2017, Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing, Sci. Rep., 7, 3628, 10.1038/s41598-017-03706-9

Prykhodko, 2018, Impact of Rye Kernel-Based Evening Meal on Microbiota Composition of Young Healthy Lean Volunteers with an Emphasis on Their Hormonal and Appetite Regulations, and Blood Levels of Brain-Derived Neurotrophic Factor, Front. Nutr., 5, 45, 10.3389/fnut.2018.00045

Kang, 2015, A Longitudinal Study of BDNF Promoter Methylation and Depression in Breast Cancer, Psychiatry Investig., 12, 523, 10.4306/pi.2015.12.4.523

Su, 2015, Plasma brain-derived neurotrophic factor levels in patients suffering from post-traumatic stress disorder, Psychiatry Res., 229, 365, 10.1016/j.psychres.2015.06.038

Roncero, 2015, Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients, Psychiatry Res., 225, 309, 10.1016/j.psychres.2014.12.019

Travison, 2007, Cortisol levels and measures of body composition in middle-aged and older men, Clin. Endocrinol. (Oxf.), 67, 71, 10.1111/j.1365-2265.2007.02837.x

Kumari, 2010, A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study, J. Clin. Endocrinol. Metab., 95, 4415, 10.1210/jc.2009-2105

Reynolds, 2010, Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: The Edinburgh type 2 diabetes study, J. Clin. Endocrinol. Metab., 95, 1602, 10.1210/jc.2009-2112

Champaneri, 2013, Diurnal salivary cortisol is associated with body mass index and waist circumference: The Multiethnic Study of Atherosclerosis, Obesity (Silver Spring), 21, E56, 10.1002/oby.20047

Joseph, 2017, Antecedent longitudinal changes in body mass index are associated with diurnal cortisol curve features: The multi-ethnic study of atherosclerosis, Metabolism, 68, 95, 10.1016/j.metabol.2016.12.001

Duclos, 2005, Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women, Obes. Res., 13, 1157, 10.1038/oby.2005.137

Schorr, 2015, Cortisol Measures Across the Weight Spectrum, J. Clin. Endocrinol. Metab., 100, 3313, 10.1210/JC.2015-2078

Tenk, J., Matrai, P., Hegyi, P., Rostas, I., Garami, A., Szabo, I., Solymar, M., Petervari, E., Czimmer, J., and Marta, K. (2016). In Obesity, HPA Axis Activity Does Not Increase with BMI, but Declines with Aging: A Meta-Analysis of Clinical Studies. PLoS ONE, 11.

Taylor, 2015, Possible Contribution of PTSD to Altered Cortisol Activity in Young Adult Obese African-American Women, J. Racial. Ethn. Health Disparities, 2, 231, 10.1007/s40615-014-0070-y

Malan, 2017, Hypothalamic-pituitary-adrenal-axis dysregulation and double product increases potentiate ischemic heart disease risk in a Black male cohort: The SABPA study, Hypertens. Res., 40, 590, 10.1038/hr.2017.5

Roberts, 2007, The effects of stress on body weight: Biological and psychological predictors of change in BMI, Obesity (Silver Spring), 15, 3045, 10.1038/oby.2007.363

Epel, 2015, Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review, Psychoneuroendocrinology, 62, 301, 10.1016/j.psyneuen.2015.08.014

Piccoli, 2015, Association of HSD11B1 polymorphic variants and adipose tissue gene expression with metabolic syndrome, obesity and type 2 diabetes mellitus: A systematic review, Diabetol. Metab. Syndr., 7, 38, 10.1186/s13098-015-0036-1

Quteineh, 2015, Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments, Pharmacogenet. Genom., 25, 246, 10.1097/FPC.0000000000000131

Crowley, 2019, Increased central adiposity and decreased subcutaneous adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance-A longitudinal cohort study, Clin. Endocrinol. (Oxf.), 91, 72, 10.1111/cen.13939

Morton, 2008, 11beta-hydroxysteroid dehydrogenase type 1 and obesity, Front. Horm. Res., 36, 146, 10.1159/000115363